by Scott Larrivee | Apr 17, 2025 | News
The following is a copy of a press release issued by Clarity Pharmaceuticals on April 17, 2025 in Australia. Minor edits have been made in this copy to account for English spelling preferences in the United States. Highlights Clarity has signed a commercial-scale...
by Scott Larrivee | Mar 14, 2025 | Utah
March 14, 2025 – Nusano’s radioisotope production platform is profiled in a Salt Lake City Business Journal article: Chris Lowe, company CEO, said the origin of Nusano was “to address the underlying problems that have plagued national research labs and...
by Scott Larrivee | Feb 24, 2025 | News
WEST VALLEY CITY, Utah – Feb. 24, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Atomiq, Inc., a cutting-edge nuclear battery technologies subsidiary of Kronos Advanced Technologies, today announced a collaboration agreement to...
by Scott Larrivee | Jan 22, 2025 | News
VALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at Piper Sandler’s Nex-Gen RadioPharma Symposium virtual event on Thursday, Jan. 23, 2025. The fireside...
by Scott Larrivee | Jan 10, 2025 | News
High-volume, breakthrough radioisotope production platform to enable innovation in life sciences and industrial applications VALENCIA, Calif. – January 10, 2025 – Nusano, a privately held physics company transforming the production of radioisotopes utilized in...